Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration
about
Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylationImpaired Mitochondrial Dynamics and Mitophagy in Neuronal Models of Tuberous Sclerosis Complex.mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders.A Mitocentric View of Alzheimer's Disease.Hepatic S6K1 Partially Regulates Lifespan of Mice with Mitochondrial Complex I Deficiency.TNFα affects CREB-mediated neuroprotective signaling pathways of synaptic plasticity in neurons as revealed by proteomics and phospho-proteomics.Bioenergetic variation is related to autism symptomatology.TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation.Mammalian target of rapamycin as a therapeutic target in osteoporosis.Acute Fornix Deep Brain Stimulation Improves Hippocampal Glucose Metabolism in Aged Mice.Regulation of MicroRNAs-Mediated Autophagic Flux: A New Regulatory Avenue for Neurodegenerative Diseases With Focus on Prion Diseases.Decreasing cytosolic translation is beneficial to yeast and human Tafazzin-deficient cells.Glucocorticoid-dependent REDD1 expression reduces muscle metabolism to enable adaptation under energetic stress.Towards a therapy for mitochondrial disease: an updateRapamycin rescues mitochondrial myopathy via coordinated activation of autophagy and lysosomal biogenesismtDNA Population Variants and Neurodegenerative Diseasesp62-Keap1-NRF2-ARE Pathway: A Contentious Player for Selective Targeting of Autophagy, Oxidative Stress and Mitochondrial Dysfunction in Prion Diseases
P2860
Q37131345-A224699F-D1D0-4BD1-98B3-4C64A8997C9AQ37364126-10FD8E2F-419A-4347-985F-E170B03ABE03Q37697798-5EA45551-0E10-4688-8200-4799F86BECC7Q38970508-3DDB455E-CD3E-4560-B0A1-873E00A913E7Q41623603-8CB28C5E-DC03-4D56-AEC6-457A53993A17Q41694180-A0D9E366-8511-4164-B768-A58A29C040F4Q44602403-D675CC6C-3FAD-4A59-AB65-CA5AB08A83DBQ47126638-7B513640-9BA6-4245-8912-C8EBC37DDD0AQ48187280-4738CE9F-9F39-413E-96F0-784356C6FAD4Q50534218-5F809005-371B-454E-96EA-B6B4232EBBE9Q55004951-77B4705F-63D0-4A79-8CA4-A1D0419E5ABDQ55309132-9396F3C4-8645-46A3-88E3-5204105580C8Q55331913-2A628D25-6D85-4023-B4E4-3A1F41C0B02BQ57293416-FE40B378-5A49-4A85-A671-8FDA62A18609Q57475800-6C9F7301-B311-4D4B-B07F-88DF8785F2CFQ58122630-FE360F5D-B9E2-4CC3-8F66-0AFA7B3DDF1CQ58583990-8627D3E3-ED34-4ACC-AB11-8F35E9CD9036
P2860
Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Alleviation of neuronal energy ...... dria-related neurodegeneration
@ast
Alleviation of neuronal energy ...... dria-related neurodegeneration
@en
type
label
Alleviation of neuronal energy ...... dria-related neurodegeneration
@ast
Alleviation of neuronal energy ...... dria-related neurodegeneration
@en
prefLabel
Alleviation of neuronal energy ...... dria-related neurodegeneration
@ast
Alleviation of neuronal energy ...... dria-related neurodegeneration
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
Alleviation of neuronal energy ...... dria-related neurodegeneration
@en
P2093
Fred H Gage
Mingji Jin
Travis Berggren
Weiwei Fan
Xinde Zheng
Yongsung Kim
P2860
P3181
P356
10.7554/ELIFE.13378
P407
P577
2016-03-23T00:00:00Z